16:17 EDT Maze Therapeutics (MAZE) files to sell 9.23M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MAZE:
- Maze Therapeutics Appoints Hervé Hoppenot as Chairman
- Maze Therapeutics appoints Herve Hoppenot as chairman of the board
- Two new option listings on September 17th
- Maze Therapeutics price target raised to $34 from $19 at Guggenheim
- Maze Therapeutics price target raised to $50 from $34 at H.C. Wainwright